Antiplatelet agents in the prevention and therapy of thrombosis.
about
Pharmacogenomics and drug response in cardiovascular disordersPotential use of a low-molecular-weight heparin to prevent restenosis in patients with extensive wall damage following peripheral angioplastyAntiplatelet therapy--Part IIPrevention of thrombosis and rethrombosis and enhancement of the thrombolytic actions of recombinant tissue-type plasminogen activator in the canine heart by DMP728, a glycoprotein IIb/IIIa antagonistDirect and indirect effects of particulate matter on the cardiovascular systemPharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.Fibrinolytic treatment for acute ischaemic stroke.Recombinant decorsin: dynamics of the RGD recognition site.Effects of 4-piperidinomethyl-2-isopropyl-5-methylphenol on oxidative stress and calcium current.Novel antithrombotic therapy.Pharmacodynamic models to evaluate antithrombotics in clinical pharmacology.Antioxidant and antiplatelet effects of dang-gui-shao-yao-san on human blood cells.Inhibitory effects of resveratrol on platelet activation induced by thromboxane a(2) receptor agonist in human platelets.Modular design, expression and characterization of novel bifunctional mutants of fibrolase with combined platelet aggregation-inhibition and fibrinolytic activity.Platelet glycoprotein IIb/IIIa receptor inhibition in primary angioplasty for acute myocardial infarction: The new paradigm of direct revascularization
P2860
Q28171051-B960B8D2-DA70-46B3-B913-F7699E7C99EAQ28190541-6353748E-DECF-43E7-94AC-92DC6D8AE968Q33606997-6E7F1C0F-4EA8-4F96-AE85-4E3CDB1B3B2CQ34793710-1363DCFA-0A50-4E28-B5CD-B776A31EF930Q35643188-0D160989-CA73-4534-84F4-C5A592075024Q36326202-972FAF6A-8102-4A54-8205-E2576C04DDD4Q36382572-D9AEFD76-1BDE-4266-926D-7279DFF03A6AQ38308551-351DF33A-B9BF-4931-8676-DDDEAAC6AD06Q40384374-A1116E64-4646-42ED-A344-79EC4FD1A757Q40725160-396E35CD-A29E-4AEC-96B3-2906457D59D3Q41361483-E2FA4F55-6424-4F9C-8EFE-8C4FDF5372C8Q46787553-5881C5F8-558C-43BE-A2F0-46124C45DBB4Q50549344-860754C4-1A2B-4AE2-8CEE-E01BF1922288Q54363660-8E0C33A5-D3CB-41E3-9BBA-ACFC52EFF7F1Q58173541-D0C2A0FD-7AFF-4A46-8CD1-90F440F91AAD
P2860
Antiplatelet agents in the prevention and therapy of thrombosis.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Antiplatelet agents in the prevention and therapy of thrombosis.
@ast
Antiplatelet agents in the prevention and therapy of thrombosis.
@en
type
label
Antiplatelet agents in the prevention and therapy of thrombosis.
@ast
Antiplatelet agents in the prevention and therapy of thrombosis.
@en
prefLabel
Antiplatelet agents in the prevention and therapy of thrombosis.
@ast
Antiplatelet agents in the prevention and therapy of thrombosis.
@en
P1476
Antiplatelet agents in the prevention and therapy of thrombosis.
@en
P2093
P304
P356
10.1146/ANNUREV.ME.43.020192.001131
P577
1992-01-01T00:00:00Z